These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Targeting the TLR4 signaling pathway by polyphenols: A novel therapeutic strategy for neuroinflammation. Rahimifard M; Maqbool F; Moeini-Nodeh S; Niaz K; Abdollahi M; Braidy N; Nabavi SM; Nabavi SF Ageing Res Rev; 2017 Jul; 36():11-19. PubMed ID: 28235660 [TBL] [Abstract][Full Text] [Related]
8. Quercetin modulates toll-like receptor-mediated protein kinase signaling pathways in oxLDL-challenged human PBMCs and regulates TLR-activated atherosclerotic inflammation in hypercholesterolemic rats. Bhaskar S; Helen A Mol Cell Biochem; 2016 Dec; 423(1-2):53-65. PubMed ID: 27665434 [TBL] [Abstract][Full Text] [Related]
9. Effects of the TLR4/Myd88/NF-κB Signaling Pathway on NLRP3 Inflammasome in Coronary Microembolization-Induced Myocardial Injury. Su Q; Li L; Sun Y; Yang H; Ye Z; Zhao J Cell Physiol Biochem; 2018; 47(4):1497-1508. PubMed ID: 29940584 [TBL] [Abstract][Full Text] [Related]
10. Potential therapeutic targets for inflammation in toll-like receptor 4 (TLR4)-mediated signaling pathways. Roy A; Srivastava M; Saqib U; Liu D; Faisal SM; Sugathan S; Bishnoi S; Baig MS Int Immunopharmacol; 2016 Nov; 40():79-89. PubMed ID: 27584057 [TBL] [Abstract][Full Text] [Related]
11. Human lactoferrin activates NF-kappaB through the Toll-like receptor 4 pathway while it interferes with the lipopolysaccharide-stimulated TLR4 signaling. Ando K; Hasegawa K; Shindo K; Furusawa T; Fujino T; Kikugawa K; Nakano H; Takeuchi O; Akira S; Akiyama T; Gohda J; Inoue J; Hayakawa M FEBS J; 2010 May; 277(9):2051-66. PubMed ID: 20345905 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists. Peri F; Piazza M Biotechnol Adv; 2012; 30(1):251-60. PubMed ID: 21664961 [TBL] [Abstract][Full Text] [Related]
14. Neohesperidin dihydrochalcone down-regulates MyD88-dependent and -independent signaling by inhibiting endotoxin-induced trafficking of TLR4 to lipid rafts. Xia X; Fu J; Song X; Shi Q; Su C; Song E; Song Y Free Radic Biol Med; 2015 Dec; 89():522-32. PubMed ID: 26453923 [TBL] [Abstract][Full Text] [Related]
15. Endotoxin induces toll-like receptor 4 expression in vascular smooth muscle cells via NADPH oxidase activation and mitogen-activated protein kinase signaling pathways. Lin FY; Chen YH; Tasi JS; Chen JW; Yang TL; Wang HJ; Li CY; Chen YL; Lin SJ Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2630-7. PubMed ID: 17008589 [TBL] [Abstract][Full Text] [Related]
16. C-reactive protein triggers inflammatory responses partly via TLR4/IRF3/NF-κB signaling pathway in rat vascular smooth muscle cells. Liu N; Liu JT; Ji YY; Lu PP Life Sci; 2010 Sep; 87(11-12):367-74. PubMed ID: 20670634 [TBL] [Abstract][Full Text] [Related]
17. The Role of RP105 in Cardiovascular Disease through Regulating TLR4 and PI3K Signaling Pathways. Yang J; Zeng P; Yang J; Fan ZX Curr Med Sci; 2019 Apr; 39(2):185-189. PubMed ID: 31016532 [TBL] [Abstract][Full Text] [Related]
18. Primary cilia modulate TLR4-mediated inflammatory responses in hippocampal neurons. Baek H; Shin HJ; Kim JJ; Shin N; Kim S; Yi MH; Zhang E; Hong J; Kang JW; Kim Y; Kim CS; Kim DW J Neuroinflammation; 2017 Sep; 14(1):189. PubMed ID: 28927423 [TBL] [Abstract][Full Text] [Related]
19. Effect of statins on toll-like receptors: a new insight to pleiotropic effects. Bahrami A; Parsamanesh N; Atkin SL; Banach M; Sahebkar A Pharmacol Res; 2018 Sep; 135():230-238. PubMed ID: 30120976 [TBL] [Abstract][Full Text] [Related]
20. [Research progress of TLR4 signaling pathway and its targeted drugs]. Zhang J; Shang D Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Jul; 37(7):657-662. PubMed ID: 34140078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]